A Clinical Study Assessing Asciminib Treatment in a Real-World Multi-Resistant Cml Patient Population
Latest Information Update: 14 Aug 2022
At a glance
- Drugs Asciminib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
Most Recent Events
- 14 Aug 2022 New trial record
- 17 Jun 2022 Results presented at the 27th Congress of the European Haematology Association